News
-
Lisata Therapeutics Announces Research License With Catalent
4/15/2025
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that the Company has entered into a research license with Catalent, Inc. (“Catalent”) to evaluate, in a preclinical setting, the efficacy of Lisata's iRGD cyclic peptide product candidate, certepetide, as a payload used in the context of Catalent’s SMARTag® antibody-drug conjugate (“ADC”) dual-payload technology platform for the treatment of difficult-to-treat-diseases, including advanced solid tumors.
-
Consulta Remedios Selects Kevel's Retail Media Cloud To Power Its Next-Generation Advertising Platform
5/2/2025
Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud to power the development and enhancement of its in-house retail media network.
-
Samsung Advances AI In Mobile Networks With NVIDIA
3/12/2025
Samsung Electronics today announced that the company is working with NVIDIA to advance AI-RAN technologies.
-
Nearfield Instruments And Singapore's A*STAR IME Sign Research Collaboration Agreement To Advance Semiconductor Metrology Solutions For AI And Advanced Packaging Era
5/20/2025
Nearfield Instruments, a leader in advanced semiconductor metrology, and the A*STAR Institute of Microelectronics (A*STAR IME) of Singapore, today have signed a multi-year research collaboration agreement to drive innovation in semiconductor metrology technologies.
-
Research Collaboration Between RIT And Cornell Produces New Technique To Enhance Sensors And Photonic Devices
1/30/2025
Researchers have discovered new ways to bend light to improve optical applications such as sensors, displays, and next-generation photonic devices.
-
INTERPHEX Announces Show Floor Tour Options In Partnership With Parenteral Drug Association And CRB Group
1/9/2025
INTERPHEX is excited to announce a new initiative to create dynamic and interactive opportunities for a broader range of attendees. Based on valuable insights from customer surveys and the INTERPHEX Attendee Advisory Committee, we are introducing reimagined Show Floor Tour options that focus on diverse industry themes. These tours are designed to maximize attendee engagement and ensure more meaningful exploration of the show floor. To bring these ideas together, INTERPHEX has partnered with CRB Group and PDA for their industry expertise.
-
Advancing Optical Precision: Metasurface Metrology With Phasics' Cutting-Edge Technology
2/24/2025
Metasurfaces are composed of tiny elements called building blocks or meta-atoms, which are used to control light where two different materials meet. These surfaces can be divided into two types: local metasurfaces, where each element works independently, and nonlocal metasurfaces, where elements are connected and work together.
-
SIU Researcher Seeks To Upcycle Food Waste Into Biodegradable Packaging
5/7/2025
It might surprise you to learn that the No. 1 type of landfill waste in the United State is food. That being the case, a researcher at Southern Illinois University Carbondale is looking for ways to divert that waste into a process for making biodegradable packaging for food.
-
New Land Grant Research Detects Dicamba Damage From The Sky
7/9/2025
Drones can now detect subtle soybean canopy damage from dicamba at one ten-thousandth of the herbicide’s label rate — simulating vapor drift — eight days after application.
-
Nxera Launches Broad Proprietary Pipeline Targeting Obesity And Chronic Weight Management
8/5/2025
Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders.